28 Jan 2016
Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team
GRAND RAPIDS, Mich. (Jan. 28, 2016)—The first clinical trial to move forward as part of the Van Andel Research Institute–Stand Up To...Read More
27 Aug 2015
Researchers mimic viral infection in colon cancer stem cells, identify druggable target to potentially root out disease, end relapse
Note: This press release was written by Princess Margaret Cancer Centre. Dr. Peter Jones, Van Andel Research Institute’s (VARI) research director, is a...Read More
20 Oct 2014
Stand Up To Cancer Epigenetics Dream Team continues with $7.5 million funding from Van Andel Research Institute
Grand Rapids, Michigan (October 20, 2014)— The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in...Read More
8 Oct 2014
Van Andel Research Institute’s research director and chief scientific officer participates in 21st Century Cures roundtable with director of the National Institutes of Health
U.S. Rep. and Chairman of the House Energy and Commerce Committee Fred Upton assembles distinguished panel to foster enhanced collaboration Grand Rapids,...Read More
24 Feb 2014
Van Andel Institute establishes global epigenetics research hub, becoming stronghouse for hot topic in cancer research
World-Renowned Molecular Biologist and New Director of Research, Chief Scientific Officer Dr. Peter Jones Leading Translational Research in Epigenetics Grand Rapids, Mich....Read More
16 Dec 2013
Van Andel Institute appoints new Director of Research, Chief Scientific Officer
World-Renowned Molecular Biologist to Help Shape Future of Research Institute Grand Rapids, Mich. (Dec. 16, 2013) – Van Andel Institute, a world-class research...Read More